Ortho evra and Septic embolus - a phase IV clinical study of FDA data

Summary:

Septic embolus is reported as a side effect among people who take Ortho evra (ethinyl estradiol; norelgestromin), especially for people who are female, have been taking the drug for 1 - 6 months.

The phase IV clinical study analyzes which people have Septic embolus when taking Ortho evra. It is created by eHealthMe based on reports of 29,122 people who have side effects when taking Ortho evra from the FDA, and is updated regularly.

What is Ortho evra?

Ortho evra has active ingredients of ethinyl estradiol; norelgestromin. It is often used in birth control. eHealthMe is studying from 29,275 Ortho evra users. Check the latest studies of Ortho evra.

What is Septic embolus?

Septic embolus (a type of embolism that is infected with bacteria) is found to be associated with 160 drugs and 282 conditions by eHealthMe. Check the latest studies of Septic embolus.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

29,122 people reported to have side effects when taking Ortho evra.
Among them, 11 people (0.04%) have Septic embolus.

Among these 11 people:

How long have people been on Ortho evra when they have Septic embolus? *

What is the gender of people who have Septic embolus when taking Ortho evra? *

female: 100 %
male: 0.0 %

What are other side effects people have besides Septic embolus? *

Torticollis (a twisted neck in which the head is tipped to one side, while the chin is turned to the other): 6 people, 54.55%
Staphylococcal Infection (an infection with staphylococcus bacteria): 6 people, 54.55%
Pneumonia: 6 people, 54.55%
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble): 6 people, 54.55%
Dehydration (dryness resulting from the removal of water): 6 people, 54.55%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 6 people, 54.55%
Arrhythmias (irregular heartbeat): 6 people, 54.55%
Acute Kidney Failure: 6 people, 54.55%
Retropharyngeal Abscess (deep neck space pus collection): 4 people, 36.36%
Pulmonary Embolism (blockage of the main artery of the lung): 3 people, 27.27%

* Approximation only. Some reports may have incomplete information.

Do you take Ortho evra and have Septic embolus?

- Check whether Septic embolus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ortho evra:

Ortho evra (29,275 reports)

Septic embolus treatments and more:

Septic embolus (1,068 reports)

How severe was Septic embolus and when was it recovered:

Septic embolus in Ortho evra

Expand to all the drugs that have ingredients of ethinyl estradiol; norelgestromin:

Septic embolus and drugs with ingredients of ethinyl estradiol; norelgestromin

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ortho evra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Septic embolus:

Septic embolus (160 drugs)

Browse all the conditions that are associated with Septic embolus:

Septic embolus (282 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ethinyl estradiol; norelgestromin (the active ingredients of Ortho evra) and Ortho evra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.